Histamine Antagonists

• 

  Subject Areas on Research

  • Plasmodium chaperonin TRiC/CCT identified as a target of the antihistamine clemastine using parallel chemoproteomic strategy. 
  • A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. 
  • An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department. 
  • Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine. 
  • Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task. 
  • New Developments in Insomnia Medications of Relevance to Mental Health Disorders. 
  • Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. 
  • Prescribing patterns of primary care physicians and otolaryngologists in the management of laryngeal disorders. 
  • Prescription Treatment Options. 
  • Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Utility of routine laboratory testing in management of chronic urticaria/angioedema.